COVID-19 infection and cardiac arrhythmias
- PMID: 32814095
- PMCID: PMC7429078
- DOI: 10.1016/j.tcm.2020.08.002
COVID-19 infection and cardiac arrhythmias
Abstract
As the coronavirus 2019 (COVID-19) pandemic marches unrelentingly, more patients with cardiac arrhythmias are emerging due to the effects of the virus on the respiratory and cardiovascular (CV) systems and the systemic inflammation that it incurs, and also as a result of the proarrhythmic effects of COVID-19 pharmacotherapies and other drug interactions and the associated autonomic imbalance that enhance arrhythmogenicity. The most worrisome of all arrhythmogenic mechanisms is the QT prolonging effect of various anti-COVID pharmacotherapies that can lead to polymorphic ventricular tachycardia in the form of torsade des pointes and sudden cardiac death. It is therefore imperative to monitor the QT interval during treatment; however, conventional approaches to such monitoring increase the transmission risk for the staff and strain the health system. Hence, there is dire need for contactless monitoring and telemetry for inpatients, especially those admitted to the intensive care unit, as well as for outpatients needing continued management. In this context, recent technological advances have ushered in a new era in implementing digital health monitoring tools that circumvent these obstacles. All these issues are herein discussed and a large body of recent relevant data are reviewed.
Keywords: Atrial fibrillation; COVID-19; Cardiac arrhythmias; Long QT syndrome; Myocarditis; SARS-CoV-2; Sudden cardiac death; Torsade des pointes; Ventricular fibrillation; Ventricular tachycardia.
Copyright © 2020 Elsevier Inc. All rights reserved.
Figures
Comment in
-
Editorial commentary: Cardiac arrhythmias in the era of COVID-19 pandemic.Trends Cardiovasc Med. 2020 Nov;30(8):461-462. doi: 10.1016/j.tcm.2020.09.001. Epub 2020 Sep 11. Trends Cardiovasc Med. 2020. PMID: 32927023 Free PMC article. No abstract available.
Similar articles
-
Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era.Circ Arrhythm Electrophysiol. 2020 Nov;13(11):e008937. doi: 10.1161/CIRCEP.120.008937. Epub 2020 Oct 1. Circ Arrhythm Electrophysiol. 2020. PMID: 33003964 Free PMC article.
-
Temporal Trends in Arrhythmogenicity Related to Treatment of COVID-19 Infection.Circ Arrhythm Electrophysiol. 2020 Oct;13(10):e008841. doi: 10.1161/CIRCEP.120.008841. Epub 2020 Sep 15. Circ Arrhythm Electrophysiol. 2020. PMID: 32931318 Free PMC article. No abstract available.
-
Incidence and treatment of arrhythmias secondary to coronavirus infection in humans: A systematic review.Eur J Clin Invest. 2021 Feb;51(2):e13428. doi: 10.1111/eci.13428. Epub 2020 Nov 26. Eur J Clin Invest. 2021. PMID: 33043453 Free PMC article.
-
COVID-19 and Cardiac Arrhythmias.Hamostaseologie. 2021 Oct;41(5):372-378. doi: 10.1055/a-1581-6881. Epub 2021 Oct 25. Hamostaseologie. 2021. PMID: 34695853 Review.
-
Arrhythmogenic Risk and Mechanisms of QT-Prolonging Drugs to Treat COVID-19.Card Electrophysiol Clin. 2022 Mar;14(1):95-104. doi: 10.1016/j.ccep.2021.10.009. Epub 2021 Oct 30. Card Electrophysiol Clin. 2022. PMID: 35221089 Free PMC article. Review.
Cited by
-
Emergence of Atrial Fibrillation and Flutter in COVID-19 Patients: A Retrospective Cohort Study.Healthcare (Basel). 2024 Aug 23;12(17):1682. doi: 10.3390/healthcare12171682. Healthcare (Basel). 2024. PMID: 39273707 Free PMC article.
-
Pathophysiological correlations between SARS-CoV-2 and arrhythmogenesis: a literature review.Germs. 2024 Mar 31;14(1):63-76. doi: 10.18683/germs.2024.1418. eCollection 2024 Mar. Germs. 2024. PMID: 39169984 Free PMC article. Review.
-
The Potential Mechanisms of Arrhythmia in Coronavirus disease-2019.Int J Med Sci. 2024 May 19;21(7):1366-1377. doi: 10.7150/ijms.94578. eCollection 2024. Int J Med Sci. 2024. PMID: 38818469 Free PMC article. Review.
-
Cardiovascular involvement in patients with COVID-19: a systematic review of prevalence studies.Br J Card Nurs. 2022 Mar 2;17(3):2022.0018. doi: 10.12968/bjca.2022.0018. Br J Card Nurs. 2022. PMID: 38813460 Free PMC article. No abstract available.
-
COVID-19 and Atrial Fibrillation: Predicting to Prevent.Arq Bras Cardiol. 2024 Apr 8;121(1):e20230823. doi: 10.36660/abc.20230823. eCollection 2024. Arq Bras Cardiol. 2024. PMID: 38597569 Free PMC article. English, Portuguese. No abstract available.
References
-
- Manolis AS, Manolis TA. Cardiovascular complications of the coronavirus (COVID-19) infection. Rhythmos. 2020;15:23–28.
-
- Parohan M, Yaghoubi S, Seraji A. Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Eur Heart J Acute Cardiovasc Care. 2020 Jun 21 doi: 10.1177/2048872620937165. . Online ahead of print. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous